Neurocrine Biosciences
NBIX
#1396
Rank
โ‚ฌ12.22 B
Marketcap
120,77ย โ‚ฌ
Share price
-0.07%
Change (1 day)
9.57%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): 1,84ย โ‚ฌ

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is 1,87ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 1,53ย โ‚ฌ an increase over its 2021 EPS that were of 0,91ย โ‚ฌ.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)1,84ย โ‚ฌ19.76%
20221,53ย โ‚ฌ69.47%
20210,91ย โ‚ฌ-78.21%
20204,16ย โ‚ฌ990%
20190,38ย โ‚ฌ81.82%
20180,21ย โ‚ฌ-113.5%
2017-1,55ย โ‚ฌ0.62%
2016-1,54ย โ‚ฌ57.28%
2015-0,98ย โ‚ฌ25.61%
2014-0,78ย โ‚ฌ18.84%
2013-0,66ย โ‚ฌ-1085.71%
20120,06672ย โ‚ฌ-89.71%
20110,65ย โ‚ฌ-500%
2010-0,16ย โ‚ฌ-86.92%
2009-1,24ย โ‚ฌ-43.48%
2008-2,19ย โ‚ฌ-57.8%
2007-5,19ย โ‚ฌ92.58%
2006-2,70ย โ‚ฌ371.67%
2005-0,57ย โ‚ฌ-52.76%
2004-1,21ย โ‚ฌ36.56%
2003-0,89ย โ‚ฌ-70%
2002-2,95ย โ‚ฌ118.31%
2001-1,35ย โ‚ฌ8.4%
2000-1,25ย โ‚ฌ68.38%
1999-0,74ย โ‚ฌ-20%
1998-0,93ย โ‚ฌ-479.31%
19970,24ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
1,99ย โ‚ฌ 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
0,52ย โ‚ฌ-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-2,82ย โ‚ฌ-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
5,18ย โ‚ฌ 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
3,51ย โ‚ฌ 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
1,77ย โ‚ฌ-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,45ย โ‚ฌ-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,89ย โ‚ฌ-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA